NYSE : JRI
$0.03 (0.23%)
| Source | Headline |
|---|---|
|
JRI: Growth Potential Limited By Portfolio Structure
Nuveen Real Asset Income and Growth Fund remains rated Hold, given its focus on high-yield income and real asset exposure. JRI trades at a 4.77% discount to NAV, but this is less attractive than its three-year average discount of 7.23%. While JRI benefits from AI-driven infrastructure growth, its income-first strategy forces it to sell upside, limiting NAV appreciation. seekingalpha.com - 2026-06-04 21:09:38 |